Monographie - Morphine tartrate - Stabilis 4.0

Ultimele actualizari :
19/11/2024

Antialgic

Morphine tartrate

Injectabil

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

pdf

Formula chimica

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Morphine tartrate

Australia

Bibliografie

Injectabil

Bibliografie : Morphine tartrate

	tip	publicare
519	ziar	Poggi GL. Compatibility of morphine tartrate admixtures in polypropylene syringes. Aust J Hosp Pharm 1991 ; 21: 316.
920	ziar	Targett PL, Keefe PA, Merridew CG. Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes. Aust J Hosp Pharm 1997 ; 27: 452-454.
980	ziar	Ambados F. Compatibility of morphine and ketamine for subcutaneous infusion. Aust J Hosp Pharm 1995 ; 25: 352.
1864	ziar	Lau MH, Hackman C, Morgan DJ. Compatibility of ketamine and morphin injections. Pain 1998 ; 75: 389-390.
2083	ziar	La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. J Pharm Pract and Res 2002 ; 32: 65-68.
3474	Laborator	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3504	Laborator	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3644	Laborator	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3675	Laborator	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3838	Laborator	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3934	Laborator	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 2016

Mentions Légales